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We performed comparative global proteomics analyses of patient-matched primary (686Tu) and metastatic (686Ln) OSCC cells.
The metastatic OSCC 686Ln cells showed greater in vitro migratory/invasive potential and distinct cell shape from their parental
primary 686Tu cells. Ettan DIGE analysis revealed 1316 proteins spots in both cell lines with >85% to be quantitatively similar
(<2 folds) between the two cell lines. However, two protein spots among four serial spots were highly dominant in 686Ln cells.
Mass spectrometry sequencing demonstrated all four spots to be α-tubulin isotypes. Further analysis showed no signiﬁcant
quantitative diﬀerence in the α-tubulin between the two cell lines either at mRNA or protein levels. Thus, two distinct isoforms
of α-tubulin, probably due to posttranslational modiﬁcation, were associated with metastatic 686Ln cells. Immunoﬂuorescence
demonstrated remarkable diﬀerences in the cytosolic α-tubulin distribution patterns between the two cells. In 686Tu cells, α-
tubulin proteins formed a normal network composed of ﬁlaments. In contrast, α-tubulin in 686Ln cells exhibited only partial
cytoskeletal distribution with the majority of the protein diﬀusely distributed within the cytosol. Since α-tubulin is critical for
cell shape and mobility, our ﬁnding suggests a role of α-tubulin isoforms in acquisition of metastatic phenotype and represents
potential target for therapeutic intervention.
1.Introduction
Oropharyngeal squamous cell carcinoma (OSCC) ranks
among the top ten most frequent cancers worldwide. Despite
recent advances in cancer treatments, the 5-year survival rate
forOSCCpatientshasnotchangedsigniﬁcantlyoverthepast
30 years, remaining at 30–50%. Most patients with OSCC
have metastatic disease at the time of diagnosis, and unlike
other malignancies, OSCC spreads exclusively via lymphatic
routes to the cervical nodes [1] .T h e5 - y e a rs u r v i v a lr a t ei s
<50% even in patients with a single unilateral lymph node
metastasis [1]. Therefore, cervical lymph node metastasis is
the major determinant of survival in patients with OSCC.
Metastasis which is deﬁned as the spread of tumor cells
from the primary site to other tissues of the body is a
complex process, involving invasion into adjacent tissues,
intravasation, arrest within the microcirculation, and estab-
lishment of new growth in regional lymph nodes and/or
distant organs [2–4]. To acquire these properties, tumor cells
undergo selective changes in their gene expression patterns,
leadingtooverexpressionofmetastasis-promotingmolecules
[5, 6]. Recent gene expression proﬁling studies have demon-
stratedthatcancer’snaturalhistory,including metastasisand
response to treatment, is indeed encoded in the primary
tumors [6–8]. Furthermore, these studies have documented
that speciﬁc gene expression patterns of primary tumors
are better than the routine clinic-pathologic indicators in
predicting metastasis, recurrence, and the patient’s overall
survival.
Tumor cells acquiring metastatic phenotype exhibit spe-
cific molecular alterations that regulate cell motility and ad-
hesion, the epithelial to mesenchymal transition (EMT),2 Journal of Oncology
and extracellular matrix remodeling. Because development
regional lymph node metastasis causes much of the mor-
bidity and incurability of OSCC, there is a critical need
to identify molecules that confer metastatic phenotype in
OSCC [1]. Although there are various methods that have
been used to identify molecules involved in metastasis, one
of the most convincing approaches is a comparative pro-
teomic analyzes of patient-matched primary and metastatic
tumor cells. Identiﬁcation-metastasis-associated proteomic
aberrationsarecriticalforthedevelopmentofnewdiagnostic
tests for prediction and detection of OSCC metastasis and
formulate treatment strategies for OSCC metastasis.
Previously, we reported the gene expression signature
thatdistinguishesprimaryandmetastatictumorcellsderived
from the same patient [9, 10]. Here, we extend our study
to characterize the proteomic signature of metastatic OSCC
cells. We identiﬁed a qualitative and qualitative diﬀerence in
theexpressionpatternofα-tubulinisoformsinmetastasizing
cells which correlates with their increased motility in vitro.
2.MaterialsandMethods
2.1. Cell Lines. Details related to primary OSCC
(MDA686Tu) and metastatic OSCC (MDA686Ln) cell lines
have been described previously [9]. Brieﬂy, the MDA686Tu
(686Tu) and MDA686Ln (686Ln) cell lines were established
simultaneously from the primary tumor and lymph node
metastasis of OSCC (T3N3B) involving the left base of
the tongue of a 49-year-old male. These cell lines were
maintained in DMEM/F12 50/50 mix (Cambrex) containing
10% fetal bovine serum (FBS), 0.4μg/mL hydrocortisone,
and penicillin-streptomycin-amphotericin antibiotic mix.
NIH 3T3 cells (ATCC, Manassas, VA) were grown in DMEM
with 10% fetal calf serum (FCS) up to 90% conﬂuent. The
medium was removed and replaced by FBS-free DMEM
medium supplemented with 50mg/mL ascorbic acid and
cultured for 24hrs. The supernatant was collected and
designated as conditioned medium and used in cell motility
and invasion assays.
2.2. Tumor Cells Motility and Invasion Assay. A modiﬁed
Boyden’s chamber method using BD Falcon Cell Culture
Inserts (BD Biosciences Discovery Labware Franklin Lakes,
NJ) is used to determine the in vitro tumor cells motility and
invasion. The BD Falcon Cell Culture Inserts containing PET
(polyethylene terephthalate) membranes (8μmp o r es i z e )
without and with Matrigel coating were used for motility
and invasion assays, respectively. The 686Tu and 686Ln cells
were harvested and resuspended into serum-free medium.
The upper chambers of the inserts were ﬁled with 500μL
of serum-free media containing 4 × 104 of cells. NIH
3T3-conditioned medium, mixed with the same volume of
DMEM-F12 with 10% FCS, was added to the lower chamber
as chemoattractant. The NIH-3T3 conditioned medium was
derived from NIH 3T3 cells grown for 24-hours in serum-
free DMEM media with 50mg/mL ascorbic acid. The plates
were incubated in a humidiﬁed environment at 37◦Cw i t h
5% CO2 for 24h. At the end the incubation, cells were
scraped from upper surface of the membrane by wiping
with a cotton swab. The cells adherent to lower surface of
the membrane (cells that migrated/invaded) were ﬁxed in
2% of paraformaldehyde for 10 minutes at 4◦C and stained
with hematoxylin and eosin (H&E). Digital images of the
stained cells were obtained from each inserts and used for
cell counting.
2.3. Ettan DIGE Electrophoresis and Peptide Sequencing. The
proteins were extracted from cell lines and quantitated with
BCA protein assay kit (Pierce). One hundred μg of proteins
from686Tuand686Lnwerelabeledby1.0nmolCy3andCy5
respectively following manufacture instruction (Amersham
Biosciences). The two labeled samples were combined and
further mixed with 2x loading buﬀer for isoelectric focusing
(IEF, 7m urea, 2M thiourea, 2% CHAPS, 50mM DTT
and 1% Phamalyte (pH3–10NL). The ﬁrst-dimension IEF
on a rod gel (12cm × F1.0mm, pH3–10) was performed
under a programmed gradient 200V to 1,500V over 18hrs
(total 25kVh). The ﬁrst-dimensional gel was equilibrated
in 1x SDS-PAGE loading buﬀer for 3hrs and loaded onto
an isocratic slab SDS-PAGE gel (8–15%) for electrophoresis
under constant current of 20mA overnight. The SDS-PAGE
gels were imaged by sequential ﬂuorescence emission spec-
troscopyusingaTyphoon9400laserscanner(GEHealthcare,
Piscataway, NJ) for each of the spectrally resolvable Cy3/5
dyes (Cy3, 532nm/580 [bp ± 15] nm; Cy5, 633nm/670
[bp ± 15]) and digital images recorded using ImageQuant
(GE Healthcare) software. Individual protein spots observed
within each of the 686Ln (Cy3) or 686Tu (Cy5) images were
then quantiﬁed and compared after volumetric rendering
using the diﬀerential in-gel analysis (DIA) algorithm within
DeCyder (v5.5; GE Healthcare) software. Individual spots
of interest that exhibited a statistically signiﬁcant diﬀerence
in volume between the two cell lines were identiﬁed. In
a conventional 2D electrophoresis under the same con-
ditions, the interested spots were picked after Coomassie
blue staining for further mass spectrometry. Mass spectral
analyses were performed in the Translational Proteomics
CoreatUTHealth.Brieﬂy,theproteinswerein-geldigestedas
previously described (http://msf.ucsf.edu/ingel.html)[ 11].
The tryptic digests were taken to dryness in a Thermo
SpeedVac and dissolved in 20uL of 2% acetonitrile, 0.1%
formic acid (solvent A). Aliquots of the digest were analyzed
by LC/MS/MS on an Agilent 6538 UHD Accurate-Mass
Quadrupole Time-of-Flight (Q-TOF) mass spectrometer
equipped with an Agilent 1260 nano-LC system. The reverse
phase chromatography was performed on Agilent High
Capacity Chip (143mm) using solvent A as initial mobile
phaseandvaryingpercentagesofsolventB(90%acetonitrile,
0.1% formic acid) to constitute a ﬁve-stage gradient elution
(5–30% B for 28mins; 30–40% B for 2mins; 40–90% B for
2mins; 90% B for 2mins; 90–3% B for 2min). Electrospray
ionization was operated at the spray voltage of 1.75kV. Mass
spectral data was extracted with MassHunter Quantitative
Analysis package and peptides were identiﬁed from MSMS
spectra with MASCOT. The MASCOT search was performed
with a peptide tolerance of 5ppm and an MSMS toleranceJournal of Oncology 3
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Figure 1: Metastatic OSSC 686Ln cells have higher invasion potentials than primary 686Tu cells. (a) Morphology of migrated OSSC 686Tu
(Tu, left panel) and 686Ln cells (Ln, right panel) on the ﬁlter after H-E staining during migration assay. Pores on the ﬁlter are visible: ×300.
(b) Summary of invasion potentials of 686Tu (Tu) and 686Ln (Ln) cells in migration and invasion assays as indicated at the top of each
graph. Invasion potentials are expressed as numbers of migrated cells in each well.
of 0.05Da, ﬁxed modiﬁcation was carbamidomethyl and
variable methionine oxidation. Identiﬁcation of nontryptic
fragments was performed manually with an initial search on
thebasisofpredictedpeptidemassesofallpossiblefragments
resulting from novel cleavage sites in the hinge region. The
MSMS spectra of suspect peaks were veriﬁed by manual de
novo peptide sequencing to conﬁrm their identities.
2.4. Immunoﬂuorescence. Cell suspensions were seeded to
eachwellof 8-wellChamber slides (FisherScientiﬁc, Roches-
ter, NY) for overnight at 37◦C, 5% CO2. The cells were ﬁxed
and permeabilized with a kit (Cytoﬁx/Cytoperm, BD, San
Jose, CA). After thorough wash with cold PBS, the cells
were ﬁrst incubated with anti-CD32 antibody and normal
goat serum for prevention of nonspeciﬁc binding of mouse
or goat IgG. The cells were then incubated with mouse
monoclonal antibody to α-actin (clone AC-40, Sigma, St.
Louis, MO) or β-actin (clone AC-1, Sigma, St. Louis, MO),
followed incubation with FITC-labeled goat anti-mouse IgG
(Southern Biotech, Birmingham, AL). The cells were further
stained by with Alex(R) 555-labelled rabbit monoclonal
antibody against α-tubulin antibody (Cell Signaling Tech-
nology, Beverly, MA). Finally, the cells were counter stained
with DAPI. The cells were observed under a ﬂuorescent
microscope (Eclipse 80i, Nikon, Tokyo, Japan). The digital
images were recorded and analyzed by NIS-Elements (Nikon
Image System).
2.5. Statistical Analysis. Two-sample t-test and one-way
ANOVA were used to determine the statistical signiﬁcance
of the diﬀerences in migration and real-time PCR between
686Ln and 686Tu lines. Statistical analyses for DIGE were
performed using ImageQuant software from GE Health.
3. Results andDiscussion
3.1. Higher Invasion Potential of 686Ln Cells Isolated from
Regional Lymph Nodes. Previously, we analyzed the glob-
al gene expression proﬁles of 686Tu and 686Ln and
demonstrated that expression levels of >90% of the genes in
cell lines derived from the primary and metastatic tumors of
the same patient were identical to each other than the two
metastatic cell lines from two diﬀerent patients [9]. In line
with the published reports, our study conﬁrmed that the
gene expression pattern of primary tumor cells are mostly
preserved in their metastatic counterpart except for a few
diﬀerentially expressed genes which are implicated in pro-
moting metastasis [9, 12]. We performed cell motility and
invasion assays to characterize the phenotypic diﬀerences
between 686Tu and Ln cells. In the cell motility assay per-
formedusingthecellcultureinsetswithoutMatrigelcoating,
686Ln cells revealed enhanced migration which was 5.5 fold
higher than that of 686Tu cells (left panel in Figure 1(b)). In
the invasion assay performed using the cell culture inserts
coatedwiththree-dimensionalMatrigel,invasionofbothcell
lines were greatly decreased. However, the reductions rates
were signiﬁcantly diﬀerent between 686Tu and 686Ln cells.
The686Lncellsshowedonly3-foldreductionascomparedto
686Tu cells with 7.1-fold reduction (Figure 1(c)). As a result,
only a 3-fold diﬀerence was observed between 686Ln and
686Tu cells when invading through Matrigel, as compared
to 5.5-fold diﬀerence when migrating through noncoated
membrane. This data suggests that the molecular machinery
thatunderliescellmotilityismorecriticalformetastaticphe-
notype than their extracellular matrix degrading molecules
which are essential for invasion through the Matrigel. Tumor
cells are known to change their phenotype during culture.
However, our result showed that the metastatic 686Ln cells
demonstratehighermotilityandinvasivepotentialthantheir
parent primary tumor cells and indicate that the phenotypic
features acquired in vivo are also preserved in cultured cells.
Therefore, this pair of cell lines represents an ideal model to
characterize proteomic signature that is causal for metastatic
phenotype.
3.2. Qualitative and Quantitative Diﬀerences in α-Tubulin
ExpressionPatternsbetween686Tuand686LnCellsareCaused
by Posttranslational Modiﬁcations. Proteins from the two cell4 Journal of Oncology
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Figure 2: DIGE gel images of primary OSSC 686Tu and metastatic 686Ln cells. (a) Cy5 image (red, left panel) and Cy3 image (green, right
panel) for 686Tu (Tu) and 686Ln (Ln), respectively. (b) Merged Cy5 and Cy3 image. Rectangular area, outlined by white line, would be
further discussed. Note that some spots in the area appear pure green or red color, suggesting their uneven quantities in the two cells.
lineswereusedforDIGE2Dgelelectrophoresis.Thescanned
Cy3 and Cy5 images for 686Ln and 686Tu, respectively,
displayed similar spot distribution patterns (Figure 2(a)). In
line with our gene expression proﬁling data, the metastatic
OSCC cells and its parent primary tumor cells revealed
almost identical cellular protein proﬁles in CyDy DIGE anal-
ysis (Figure 2(a)). Based on our previous testing, over 5-fold
diﬀerenceinaproteinoftwosourceswouldgenerateobvious
green or red spot. In combined image, dots with obvious
green or red color were visible (Figure 2(b)). Squared area
in Figure 1(b) is an example to show diﬀerent colors. With
2 × 104 pixels as background, the software detected 1316
protein spots in combined image for 686Tu (Cy5) and 686Ln
proteins (Cy3), see Figure 3.P i x e lv o l u m ef o re a c hs p o tw a s
calculated and compared between 686Ln and 686Tu cells
using 686Tu as standard. Plot with log volume ratios against
spot numbers ﬁt well with Gaussian distribution (R2 =
0.9629) with 0.032 ± 0.16 in Log scale or 1.033 ± 1.176
folds (Figure 3). To estimate how closely the two cell lines
were related, we used 2-fold diﬀerences in pixel volume
as threshold. Calculation demonstrated that 686Ln and
686Tu cells showed similar volumes in 1159 spots (88.1%),
suggesting their close relationship. In addition, 686Ln cells
showed increased volume in 70 spots (5.3%) and decreased
volume in 87 spots (8.6%), as compared to those of 686Tu
cells. However, most spots with diﬀerent volumes between
the two cells clustered between 2 to 4 folds (Figure 3).
In this study, we solely focused on the protein spots,
which were signiﬁcantly increased in 686Ln. Plot of log
volume ratio versus max volume revealed two protein spots
which showed more than 5-fold increase in 686Ln cells with
volumes higher than 2 × 107 pixels (arrows in Figure 3).
T h e s et w op r o t e i ns p o t sw e r ei d e n t i ﬁ e dt ob et w og r e e n
spots in an acidic region (pH5–5.5) with molecular weight
40–60kD (squared area in Figure 1(b)). These two green
spots were among series of 5 dots with similar molecular
masses of 55kD. The two green spots migrated to higher
pH region (pH5.5). Those 5 proteins were designated as
number 1 to 5 with number 1 and 2 for the two green
spots (Figure 3(a), arrows in Figure 3). Calculation of pixel
volumes demonstrated that number 1 and 2 in 686Ln cells
were 7.5 and 7.1 folds of those in 686Tu cells. On the otherJournal of Oncology 5
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Figure 3: Scattergram depiction of DIGE data to generate protein
expression proﬁle of 686Tu and 686Ln cells. Each dot represents a
protein detected in 686Tu and 686Ln cells. The dots are expressed
as bigger pixel volume in either cell (right Y-axis), and plotted
against log scale of pixel volume ratio between 686Tu and 686Ln
(X axis), with 686Tu as standard. Two vertical lines indicate two-
fold diﬀerence limits between the two cells. Left Y- a x i si sn u m b e r
of spots at certain pixel ranges. Related pink curve is actual
distribution of spots versus their pixel volume ratio and green curve
is normalized Gaussian distribution (R2 = 0.963). Arrows indicate
two protein spots to be studied.
hand, volume ratios between 686Ln and 686Tu cells were
1.02, 0.76, and 0.69 for spots number 3, 4 and 5, respectively.
At least three spots in the adjacent area were found to be
greatlyincreasedin686Tucells(red,numberedasnumber6–
8,Figures2and3).However,wedidnotexploretheidentities
of these spots in this study.
We next performed a routine preparative 2D electropho-
resis of proteins from 686Ln cells (Figure 4). Based on the
spots distribution pattern, spots number 1, 2, 4, and 5 were
excised for mass spectrometry based peptide sequencing
(Figure 4).Spotnumber3wasnottestedduetoitslowquan-
tity. Sequencing analyses demonstrated that spots number 1
and2wereα-tubulin.Multipleproteins,includingα-tubulin,
β-tubulin, and others, were detected in spots number 4
and 5, probably due to their merge with protein spots of
slightly higher mass (see Figure 3(a)). However, the majority
of peptides matched to α-tubulin. Our previous microarray
data showed that expression levels of α-tubulin transcripts
are not signiﬁcantly diﬀerent between 686Tu and Ln cells
whereas β-tubulin is one of the highly expressed genes in
metastaticOSCCcells[9].Tofurtherconﬁrmthemicroarray
data on α-tubulin, we performed quantitative real-time RT-
PCR analysis. Quantitative RT-PCR demonstrated that copy
numbers of α-tubulin mRNA in 686Ln cells are marginally
higher than 686Tu cells but the diﬀerence was not signiﬁcant
(Figure 5). When we calculated the sums of four spots
representing the α-tubulin protein in these cell lines, we
found that total α-tubulin protein amount was increased
by 1.27 folds in 686Ln cells (9.01 × 107 pixels, 1.27-fold)
compared to 686Tu cells (7.08 × 107 pixels, see Figure 5).
Although the above data revealed only marginal increase in
α-tubulin expression at both mRNA and protein levels in
metastatic cells compared to its parent primary tumor cells,
this small quantitative diﬀerence is unlikely to play a causal
role in their motility diﬀerences.
Next, we examined whether the immunoﬂuorescence
staining patterns of α-tubulin protein in this pair of cell lines
would reveal any remarkable quantitative and/or qualitative
diﬀerences. Overall, 686Ln cells showed a higher intensity
of anti-α-tubulin immunoﬂuorescence staining compared
to 686Tu cells (Figure 6). Both cell lines demonstrated a
higher density of α-tubulin expression in their perinuclear
region. A comparison of the staining patterns of α-tubulin in
686Tu and Ln cells showed signiﬁcant qualitative diﬀerences
in the α-tubulin ﬁlament distribution. In 686Tu cells, α-
tubulin proteins formed a network composed of coarse
ﬁlaments, probably associated with cytoskeleton. Pattern of
this network was similar to those in many other cell types
including nontransformed cells [13]. In contrast, α-tubulin
in 686Ln cells exhibited only partial cytoskeletal distribution
with majority the protein diﬀusely distributed within the
cytosol. As a result, a uniform ﬁlament network as seen
in 686Tu cells was not evident in 686Ln cells (Figure 6).
Examinationofthecellsunderhighermagniﬁcationrevealed
that the cytoskeleton of 686Ln cells is composed of a
network of much ﬁner α-tubulin ﬁlaments (Figure 6). It
should be noted that the 686Tu and Ln cells exhibit distin-
guishable morphologies, especially after migrating through
the barrier membrane during motility and invasion assays.
Almost all 686Tu cells displayed a round-ﬂattened shape
(Figure 1(a)). In contrast, more than 80% of 686Ln cells
were elongated and branched, with only a small fraction to
be in round spread shape (Figure 1(a)). Hence, we asked
whether the unusual α-tubulin network in 686Ln cells
was due to overlapping of multiple layer of the network
because of their elongated and rounded morphology. We
selectively examined a number of 686Ln cells with ﬂattened
morphology and found that none of these cells exhibited
α-tubulin staining pattern similar to that of 686Tu cells.
This ﬁnding suggests that the observed diﬀerence in the α-
tubulin networks between 686Ln and 686Tu cells was not
an artefact related to the cellular morphology. Moreover,
we compared the immunoﬂuorescences staining patterns
of α-actin and β-actin in these two cell lines and showed
that their staining patterns are indistinguishable between
686Tu and 686Ln cells (Figure 6). The sizes of α-a n dβ-
actin ﬁlaments are similar between these two cell lines,
except for minor diﬀerences in their distribution patterns.
These ﬁndings strongly suggest that the altered α-tubulin
ﬁlament distribution pattern in 686Ln cells is most likely
due to its posttranslational modiﬁcation resulting in altered
polymerization and/or increased solubility.
Our proteome analysis conﬁrms that two distinct iso-
forms of α-tubulin are found in higher quantity in 686Ln
than in 686Tu whereas the other two α-tubulin isoforms are
not. Moreover, there is no signiﬁcant quantitative diﬀerence
either in the α-tubulin transcripts number or total protein
levels between these two cell lines. It raises an interesting6 Journal of Oncology
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Figure 4:Comparisonofproteinspotsbetween686Tuand686Lncellsinrectangulararea(seeFigure 1(b)).(a)Enlargedimagesofinterested
area for 686Tu (Tu, left panel) and 686Ln cells (Ln, right panel). Some spots are numbered. Note that spots number 1 and 2 are absent in
686Tu cells, while number 6, 7, and 8 are missing in 686Ln. (b) 3D simulation of spot number 1 in 686Tu and 686Ln cells. (c) Comparison
of pixel volumes of spots number 1 to 5 between the two cells. Pixel volumes are calculated with 3D simulation.
question whether these two distinct α-tubulin isoforms
detected in 686Ln cells are unique for metastatic phenotype.
Although our study does not provide direct evidence to
support that the diﬀerences in the α-tubulin isoforms
and distribution pattern in 686Ln cells are causative for
metastasis,publishedreportshavesuggestedacriticalrolefor
tubulin isoforms in tumor cells motility and metastasis.
Microtubules, a major component of cytoskeleton are
involved in various cellular processes such as cell division,
intracellular organelle traﬃcking, secretion, maintenance of
cell shape, and motility. Tubulin (100kDa of two subunits),
a major component of microtubules, is a heterodimer of α-
andβ-tubulinisotypeswhicharetranslatedfromsevengenes
[14]. Diﬀerential expression of α-and β-tubulins isotypes are
associated with tumorigenesis, metastasis, and resistant to
chemotherapy [15–18]. Increased expression of class IV β-
tubulin isotype in breast cancer cells confer them increased
resistance to docetaxel [16]. Docetaxel and paclitaxel are
antimitotic chemotherapy drugs used for treating metastatic
breast cancer. These drugs bind to β-tubulin and halt
cell division at metaphase by preventing spindle assembly
[19]. In contrast to β-tubulin, α-tubulin isotypes undergo
signiﬁcant posttranslational modiﬁcations that determine
microtubule assembly, distribution pattern, and cellular
phenotype. Polyglutamylation and detyrosination of α-
tubulin are frequently noted in prostate cancer cells but not
in nontransformed prostate epithelial cells [20]. Increased
expression of acetylated of α-tubulin is speciﬁc for aggressive
hormone-refractory prostate cancer cells [17].
Although it is not clear whether tubulin is directly
involved in metastatic process, recent studies suggest that
abnormal assembly of tubulin monomers may be associated
withtumorigenicandmetastaticphenotypes[15–17,21–25].
Several potential mechanisms have been proposed. Micro-
tentaclesformedbytubulinsinbreastcancercellsaccelerated
cell detachment from ECM, which was a necessary step for
metastasis [26–28]. Active disassociation and re-assembling
of tubulins promotes cancer cells motility [29].
It has been shown that the cell motility is modulated by
α-tubulin acetylation/deacetylation by impacting the assem-
bly and disassembly of microtubules [30, 31]. Although the
enzyme responsible for α-tubulin acetylation is yet to be
identiﬁed, deacetylation of α-tubulin is catalyzed by histone
deacetylase 6 (HDAC6) [32]. On the other hand, HDAC6
inhibitor blocks tumor cells migration and reduces their me-
tastatic potential by inducing acetylation of α-tubulin [33].Journal of Oncology 7
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Figure 5: 686Tu and 686Ln cells expressed comparable levels of α-tubulin. (a) Quantitative RT-PCR detection of mRNA for the genes as
indicated in 686Tu and 686Ln cells. The quantities of mRNA are expressed as relative abundance using GAPDH in 686Tu as 100%. (b) Total
pixel volumes of α-tubulin in 686Tu and 686Ln cells.
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Figure 6: Metastatic 686Ln and primary 686Tu cells show a diﬀerent cellular distribution pattern of α-tubulin. 686Tu (Tu, upper row) or
686Ln cells (Ln, lower row) were stained for α-tubulin (red) and β actin (green). The cells were counterstained by DAPI. Note that 686Ln
cells show defuse α-tubulin distribution, in contrast to ﬁlament network in 686Tu cells ×600.
Our ﬁndings indicate that the morphologic changes
exhibited by 686Ln cells during their in vitro migra-
tion/invasion are reminiscent of morphologic features asso-
ciated with epithelial-mesenchymal transition (EMT) in
which epithelial cells acquire ﬁbroblast-like properties [34].
Epithelial malignant tumor cells are critically dependent on
EMT for their invasion and metastatic spread [34]. Recently,
it was reported that transforming growth factor-β1- (TGF-
β1-) induced EMT in tumor cells is indeed mediated by
deacetylation of α-tubulins by HDAC6 [35]. Previous studies
on tubulin family have shown that members of α-tubulins
have very similar molecule weight and isoelectric point,
which make them diﬃcult to be separated even in 2D
electrophoresis. Moreover, both tubulin spots speciﬁc for8 Journal of Oncology
686Ln cells were characterized as α tubulin 1C. Based on
the published reports and our ﬁndings, we propose that
two isoforms of α tubulin in metastatic 686Ln are caused
by posttranslational modiﬁcation, most likely deacetylation.
Diﬀuse distribution of α tubulin in 686Ln suggests relatively
unstable microtubules or presence of soluble α tubulins due
to posttranslational modiﬁcations [18, 36]. However, the
biochemicalfeaturesof these posttranslational modiﬁcations
remain to be explored. Although the ﬁndings of this study
are encouraging, the data are preliminary based on in vitro
studies. Hence, this data needs to be conﬁrmed in vivo by
examining a larger number of patient matched primary and
metastatic OSCC tumor sections.
4. Conclusion
In conclusion, metastatic OSCC cells exhibit increased in
vitro motility and Matrigel invasiveness than their parental
primary tumor cells derived from the same patient. We iden-
tiﬁed two distinct α-tubulin isoforms speciﬁc for metastatic
cells that are not present in its parental primary tumor cells.
Moreover, α-tubulin ﬁlaments exhibit distinctly diﬀerent
distribution pattern in metastatic cells compared to its
parental primary tumor cells. We, therefore, propose that
diﬀerential posttranslational modiﬁcations of α-tubulin are
involved in acquiring metastatic phenotype in OSCC and
characterization of these speciﬁc modiﬁcations may open
new avenues for therapeutic intervention against OSCC
metastasis. However, it remains to be determined whether
the diﬀerential expression of metastatic phenotype-speciﬁc
α-tubulin isoforms can be demonstrated in patient-matched
primary and metastatic tumor specimens.
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